Workshop Outcomes – personal reflection pieces from workshop participants

 

Results of Participant Feedback on Safety First Workshop

March 2-3, 2001

 

Question: What worked well for you during the workshop?

 

a. Broad perspectives of speakers, coming from several disciplines

b.  Interactive breakout groups

c.  Facilitator’s style

a.  Small group discussion.

b. The presentation format.

The organizers brought together a very diverse group of participants—lawyers and historians were especially good contributors; also those involved in policy development and NGOs.  The inclusion of a few more hard-core scientists would have spiced up the discussions.

Very well organized in terms of use of our time; good opportunities to get to know fellow participants.

a.  Great setting, Humphrey Center worked wonderfully (right size).

b.  Great dynamics (monitoring, microphones).

c.  Great conference folder.

The dialogue between a diverse set of speaker and audience.  Excellent selections.

Everything worked very well for me as a print media person.  Access was excellent. It was a very well designed intentional community for three days. Well planned, well received, folks had great opportunity to do well.  It reminded me of the best conferences I’ve ever attended.

Very open discussion—good.  Surprised at employing a moderator—it worked well; I haven’t really seen that before. Really liked the personal perspectives worksheet.

 

Introduction to “safety science” and history before biotech ever brought up and we were asked to apply safety concepts to issue at hand.  Very “organic” process.

Lots of discussion and questions and answers.

a.  Cross-disciplinary make-up of participants

b.  The organization.

Design is excellent—facilitates thought, reflection, and good discussion. Great facilitation. Format was perfect.

The small groups actually needed more time to go through the three questions, despite the extension of lunch.  The discussion questions were excellent and so prompted a rigorous discussion.

The participatory workshop was a great way to get everyone involved.

A lot of great information on the first day.  Final panel of first day—interesting, but didn’t really address question.

The discussions were excellent, and were well managed to ensure broad participation.

a.  Hearing the different opinions.

b.  The range of participants.

c.  International perspective.

The positive tone, non-aggressive attitudes.  Openness.

a.  My ergonomically correct chair.

b.  Workshop design/conference design

c.  Brian’s facilitation—his strategy was excellent and his tactics outstanding

d.  My breakout group (orange) came together well, my moderator was very good.

Atmosphere; organization; the quality/consistency of the conference’s package; the quality of the speakers; the good motivation (a merit of the facilitator and organizers) achieved by the audience.

a.  Group discussion on second day helped pull together the ideas which were presented the first day.

b.  Excellent range of ideas/representatives presented, new perspectives on the issue.

The allocation between presentation time and Q&A session time was a very effective method of first framing the issues and then exploring the scope and nuances of the issues.  The panels had sufficient diversity to cover issues from varied perspectives.

Very interesting!! I especially liked that the workshop did not put too much time on the present scientific controversy around GMOs, but lifted the discussion up to a higher level.

a.  Hearing different “stories” from disciplines, experience.

b.  The beginning of comparative evaluation: “what is the GMO ‘industry?’”  Have we seen something like this before and/or what have we learned?

Interdisciplinary approach worked very well.

Debate was more open than I thought.

Panelist presentations were valuable, as were the Q&A sessions, although the Q&A sessions were always too short.  Saturday morning discussions were especially informative.

It was a pleasant surprise to have food that was provided and prepared in a manner consistent with the principles you articulate. 

○○○

­­­­­­­­­­­­­­__________________________________________

 

Question: How would you improve workshops like this in the future?

 

a.  Longer time for breakout groups, less time for hearing from organizers about  issues (much was repetitive), although what was said was important.

b.  We needed to evaluate the current system for biotechnology oversight in the context of safety first and then identify specific examples of improvements—many safety first elements are in current system, many are not or are not adequate.  But there was little substantial discussion of this comparison.

a.  Open it to the public.

b.  More open discussion, some way to avoid the mic.

c.  Generate a summary of what we did her and have a press release to let folks know what is being discussed.

d.  Perhaps have a goal of generating some statements, goals that would culminate the conference.

The small-group discussions were especially beneficial.  I might reduce the number/length of large group discussions in favor of al least one additional small-group session.

A little more room for comments to follow on one another; fewer breaks in good discussions.

Like to hear more from the biotech end (Monsanto, etc.) though J. Wolt and others were insightful.

No good ideas.  Perhaps having the dinner after Day 1. I had to leave that first evening but I suspect many folks may have left before the dinner as well.

Repeat this effort with continued offers for all attendees to share their experience, knowledge, and histories.  Repetition. Designed inclusiveness, understanding leadership.  Real poetry from a great dynamic mediator poet.

To improve such a workshop I would add an example that can be worked through (certainly it would be difficult and time consuming for this topic).  I really like the theory and a discussion of process is necessary, but adding an example for content and context may help people focus.

Hand-outs to participants ahead of workshop so they could be read to prepare-- particularly information directly related to safety models and the ISEES draft plan.

Have it be open to the public; include international perspectives.

a.  Not at all.

b.  Get a policy person to give us a GMO policy map talk as a context setter.

a.  More time for dialogue.

b.  More focused information on systems theory, holistic perspectives; longer contexts in which these discussions occur, e.g. public policy in the US is for cheap food—how does this impact the entire discussion

1.  What is the role of choice (consumer, producers/farmers, species) in Safety First discussions?

2.  How does this relate to labeling issues?

3.  Farmers should be involved in the dialogue.

If I had received the written materials a week prior to the workshop, I could have responded better to the Safety First framework.  I would next deal with Safety First on a case history basis, both for GE approvals and for broader technology options assessment.

The applicability of Safety First historical lessons to GE will depend on the ability of a wide range of participants and on the willingness to engage the liability issue as a framework, rather than as an end of pipeline consequence of design or implementation of a GE product or process.

Integrate exercises that have people up and moving around.

a.  Questions to panel were often irrelevant, off-topic, personal statements— moderator could have made it clear he would only accept clarifying questions related to presentation—cut off such out-of-place remarks.

b.  Stu Hann—told us the same four points—four times—not appropriate wrap-up.  Made me angry for wasting my time.

c.  Wrap up too long on Day Two as well.

Encourage a wider range of participation, especially by representatives of sectors (other than plants) of the biotech industry not present here (e.g. aquatic, microbial, trees.)

More small group time, perhaps provide targets for discussion (?), farmers.

Include economists, insurance risk managers, psychologists to get greater input into addressing risk assessment.

a.  Make it longer—four days.

b.  Continue attempts to get more industry (product developers and product commercializers) representatives to future sessions.

c.  Continue efforts to get more representatives from developing countries.

d.  Mechanical detail:  For “key messages” feedback packet when you have multiple breakout groups:  Add check boxes to indicate “which color dot” the writer’s group was.  For each breakout group, block key messages.

a.  Distribute participants’ list up front

b.  Involve concerned government officials of the highest possible level:  a lot of tasks will be given to government in the adoption of the Safety First approach. Therefore, involving them since the beginning will be a very positive move.

a.  First day should have ended at 5pm—exhaustion of group by that time.

b.  Writing down the “Key messages—blue paper” seemed like overload, although I understand the value it would have for you.

Although extraordinarily difficult to do, it would help if discussions could avoid or limit exploration of the exceptions and concentrate on the “bell curve” area. Exceptions are best discussed later during the evolutionary process.

Longer time for discussion in the groups.  The dinner in the “middle” of the workshop—a lot of people were leaving the last evening.

I was ready for more task specific help, such as the time we spent with the Safety First team.

Shorten first day.  More industry involvement.  Especially regulatory process for new kinds of drugs, pesticides.

Work done is important information that should be documented, with follow-up, continuity, make cumulative.

Attempt to come to some decision on what specifically needs to be done in the future.

○○○

___________________________________________

 

Question: What is one thing you learned at the workshop that you will share with others?

 

Importance of learning from other fields to improve GEO oversight.

The need to establish an international, industry wide set of safety objectives.

The small-group discussions were especially beneficial.  I might reduce the number/length of large group discussions in favor of al least one additional small-group session.

The regulatory process (monitor and enforcement) practices are inconsistent at best in the United States to deal with GMOs.  Internationally—the situation is worse.  This compounds a problem when released can no be recalled.

That strict liability is unlikely to provide an incentive for stronger safety evaluations.

It’s possible to fix this GE food problem before it gets any worse.  This group together has each and every ingredient to change the present BAD results.

The history of a movement/issue is a great starting point to inform current activity/policy.  Also, looking at other industries is a great way to “think out of the box.”

The concept of “safety first” and the lessons learned and the structures used as examples.

Historical perspectives.

GMOs are happening and they are not safe, nor likely to be.

The need for informed and honest dialogue between the stakeholders is key to any progress on these issues.

People with widely divergent perspectives can reason together.

The applicability of Safety First historical lessons to GE will depend on the ability of a wide range of participants and on the willingness to engage the liability issue is a framework, rather than as an end of pipeline consequence of design or implementation of a GE product or process.

That transparency and openness are key factors in initiating an honest movement in biotech paradigms.

Possible application as a whole new paradigm, safety first.

The rampant spread of GMOs has already occurred without public input.

a.  Hazards are broader than chemical and physical systems that influence human food and environment.

b. There are GMO concerns that must be considered by those who currently reject or ignore them.

c.  Social concerns and impact need to be considered.

d.  Chicanery of GMO companies and biochemists during last 18 years as they defeated adequate and effective regulation (from Sunday.)

e.  GMO products may not be subject to strict liabililty.

The notion of establishing safety standards up front, before starting product development.

The GMO debate is a system design problem.

Dr. David Andow’s observation that “when knowledge is limiting, the rule of thumb rules.”

The “umbrella” thought that Safety First is!  The involvement of other scientific disciplines—aircraft system engineers, historians, etc.

The nuclear regulatory case and what we can learn from that for GMOs.

There is enormous dissatisfaction with the current regulatory system among all stakeholders.

We need to work harder to include public input in decisions.

○○○

___________________________________________

 

Question: Please rate the workshop on a scale of  0-10 (0 = terrible, 5 = okay, 10 = excellent).  Briefly, why did you give it this rating?

 

(7 & 8)  Excellent energy in the group and intriguing ideas but key features missing [from my perspective (see item #2)].

(8)  In many ways I felt this was one of the best run conferences I’ve been to (logistics were sweet), but I felt the objectives were a little unclear at the end.

(9)

(10)  I thought it was fantastic.

(10)  Everything went smoothly (great, diverse intelligent crew!)

(9 & 10)

Informative from a wide variety of perspectives. Current; important.

(10)  Because I’ve worked on this issue from many different angle, attending 600+ workshops, conferences, seminars, individual meetings.

 (9)  Great mix of people—even more would be even better, e.g. senators/state representatives/students/industry executives/educators/and many more people from outside of U.S./E.U.

 (10)  Extremely well designed for learning and discussion.  Comfortable.

 (9)  It was seeking ideas and not trying to push an agenda.

 (10)  Because there was really nothing better that could be done.

 (8)  Well organized; thought provoking; not long enough!

 (10)  Lively, productive discussions.  Open.

 (9)  The presentations were mostly relevant to the theme and purpose of the meeting.  Discussion groups mostly responded and offer creatively to the workshop questions.

 (8)  I thought it was great but like anything else, can always be used to look back on and see where improvements are needed.

 (8)  Very interesting presentations on Day One.  We can definitely learn from history.

 (9)  Excellent discussion—not perfect because of unequal representation (lots of academics, few biotech industry types.)

 (7)  It was educational.

 (8)  See above.

(9)  It was good; my impatience to get going with developing Safety First led me to want it to go faster.

 (9)  Overall, an excellent conference.

 (8 & 9)  Great workshop, good variety of perspectives.  First day long, although interesting, but to make it a “9,” keep entire day to no more than 8 hours.

 (7)  The workshop provided me with useful insights for my field.  But I don not work in genetic engineering or with GMOs.  Thus, much of the discussion, while interesting, was not relevant to my field.

 (8)  I would have given it a “10” if we had had better time for discussion in the groups.

 (8)  As a newcomer, I don’t have the ability to compare it to other conferences on GMOs.  It appears to be a very good balance between content and process with open dialogue.

 (9)  Well organized, good topics.  Good speakers.

 (8) 

 (8)  Excellent topic and format, but need more government participation.

○○○

___________________________________________

 

Question: Other comments on the workshop?

 

Overall, this workshop was very worthwhile.  Great Job.

It seems to me that perhaps this is reactionary and we may be playing catch-up.  Perhaps safety first in regards to GMOs needs to look at what is coming and establish safety objectives for these products.

Thanks!

I think the size of group and mix was just right, though even more diversity would have been great, too.

Thank you!

a.  I think it would have been good to have some agency regulators (EPA, USDA) represented to share their perspectives.  I would also have liked to hear from GMO opponents from Europe, in a case-study manner, as per the 2 “grim reapers” who spoke of Pb and VC.  Why is Europe so much more cautious, and how does their approach to safety issues differ, if at all, from the U.S.

b.  Also, I think the manner in which the modern media covers the issue and portrays problems will be/is an important difference in regard to historical abuses of safety issues by industry.  A media representative at a high level would have been a valuable person since they are the filter through which the public is screened.

This “one” was the first to put both/many sides in one room with community well-being as the goal.

I’d be interested in hearing ISEES staff speak a bit more.  Where did this topic come from?  How have ISEES considered it prior to this workshop?

Excellent food—support local restaurants.

The facilitation was brilliant. A paper on alternatives to GMOs was missing.

I’m worried about the follow-up aspects of this work—how will this be done? What will the opportunities for future dialogues be?

Good food.

I would agree that other categories of participants should be included: farmers, investors and/or biotech bankers, food processors and retailers.

Resultant discussion too abstract.  I would have liked to have seen a more concrete focus in the end—some real, well-defined  process.

Glad you did it.

Am looking forward to see the impact.

Thank you!

Great idea and process.  Innovative approaches to bring the stakeholders together to move the momentum towards a new paradigm in design, and consultation and development.  Brian did a superb job as usual—very positive energy.

The execution of the workshop was superb.  Events flowed smoothly and I had a great awareness of how each step fit in the overall workshop.

Keep on!  The idea is great!

Needs case studies of actual biotech regulation.

Need to write workshop thoughts on big piece of paper.  Develop consensus, more task oriented.  You compared biotech foods to other technology, but not to more related technologies like dietary supplements, drugs, and agricultural biotech vs. medical biotech.  When does a food become a drug?  The distinctions are blurring.  More legal understanding on patent laws, regulations, and food and drug laws.

 

***

a.  In talking with [another participant], he brought up the very close relationship between bioengineering, bioterrorism, and biowarfare.  His perspective was something along the lines of what Mark Wheelis might have presented.  [He] pointed out that it may be the possibilities or realties of bioterrorism, and biowarfare that ultimately lead to close scrutiny and regulation of the agricultural biotech industry.

b.  In the same conversation, the possibility not just of strict liability but of personal liability was brought up.  That is, if every scientist were held personally responsible and liable for the constructs he/she created, then scientists might act more responsibly.

c.  In a different conversation, the need for a paradigm shift in teaching was mentioned.  Many (most) students who learn bioengineering techniques know very little or nothing about ecology, behavior, ethics, and this prevents them from considering the consequences of their actions in a larger context.  The issue of ethics was brought up repeatedly, as was the failure of current institutions of higher learning to adequately prepare students for complex decision-making.

d.  The issue of the somewhat artificial separation of “human health effects” from “environmental effects” was brought up.  Environmental effects ultimately ARE human health effects, and should be considered so (though this is apparently prohibited under international treaties.)

 

***

It was a pleasant surprise to have food that was provided and prepared in a manner consistent with the principles you articulate.